purchase customization

1 Study Coverage
1.1 Antineoplastic Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Antineoplastic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Chemotherapeutic Agents
1.2.3 Biological/Immunotherapeutic Agents
1.2.4 Personalized Medicine
1.3 Market by Application
1.3.1 Global Antineoplastic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Cancer Rehabilitation Centers
1.3.5 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antineoplastic Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Antineoplastic Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Antineoplastic Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antineoplastic Drugs Sales by Region
2.4.1 Global Antineoplastic Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Antineoplastic Drugs by Region (2023-2028)
2.5 Global Antineoplastic Drugs Revenue by Region
2.5.1 Global Antineoplastic Drugs Revenue by Region (2017-2022)
2.5.2 Global Antineoplastic Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antineoplastic Drugs Sales by Manufacturers
3.1.1 Global Top Antineoplastic Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Antineoplastic Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antineoplastic Drugs in 2021
3.2 Global Antineoplastic Drugs Revenue by Manufacturers
3.2.1 Global Antineoplastic Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Antineoplastic Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antineoplastic Drugs Revenue in 2021
3.3 Global Antineoplastic Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antineoplastic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antineoplastic Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antineoplastic Drugs Sales by Type
4.1.1 Global Antineoplastic Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Antineoplastic Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Antineoplastic Drugs Sales Market Share by Type (2017-2028)
4.2 Global Antineoplastic Drugs Revenue by Type
4.2.1 Global Antineoplastic Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Antineoplastic Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antineoplastic Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Antineoplastic Drugs Price by Type
4.3.1 Global Antineoplastic Drugs Price by Type (2017-2022)
4.3.2 Global Antineoplastic Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antineoplastic Drugs Sales by Application
5.1.1 Global Antineoplastic Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Antineoplastic Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Antineoplastic Drugs Sales Market Share by Application (2017-2028)
5.2 Global Antineoplastic Drugs Revenue by Application
5.2.1 Global Antineoplastic Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Antineoplastic Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antineoplastic Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Antineoplastic Drugs Price by Application
5.3.1 Global Antineoplastic Drugs Price by Application (2017-2022)
5.3.2 Global Antineoplastic Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antineoplastic Drugs Market Size by Type
6.1.1 North America Antineoplastic Drugs Sales by Type (2017-2028)
6.1.2 North America Antineoplastic Drugs Revenue by Type (2017-2028)
6.2 North America Antineoplastic Drugs Market Size by Application
6.2.1 North America Antineoplastic Drugs Sales by Application (2017-2028)
6.2.2 North America Antineoplastic Drugs Revenue by Application (2017-2028)
6.3 North America Antineoplastic Drugs Market Size by Country
6.3.1 North America Antineoplastic Drugs Sales by Country (2017-2028)
6.3.2 North America Antineoplastic Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antineoplastic Drugs Market Size by Type
7.1.1 Europe Antineoplastic Drugs Sales by Type (2017-2028)
7.1.2 Europe Antineoplastic Drugs Revenue by Type (2017-2028)
7.2 Europe Antineoplastic Drugs Market Size by Application
7.2.1 Europe Antineoplastic Drugs Sales by Application (2017-2028)
7.2.2 Europe Antineoplastic Drugs Revenue by Application (2017-2028)
7.3 Europe Antineoplastic Drugs Market Size by Country
7.3.1 Europe Antineoplastic Drugs Sales by Country (2017-2028)
7.3.2 Europe Antineoplastic Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antineoplastic Drugs Market Size by Type
8.1.1 Asia Pacific Antineoplastic Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Antineoplastic Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Antineoplastic Drugs Market Size by Application
8.2.1 Asia Pacific Antineoplastic Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Antineoplastic Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Antineoplastic Drugs Market Size by Region
8.3.1 Asia Pacific Antineoplastic Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Antineoplastic Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antineoplastic Drugs Market Size by Type
9.1.1 Latin America Antineoplastic Drugs Sales by Type (2017-2028)
9.1.2 Latin America Antineoplastic Drugs Revenue by Type (2017-2028)
9.2 Latin America Antineoplastic Drugs Market Size by Application
9.2.1 Latin America Antineoplastic Drugs Sales by Application (2017-2028)
9.2.2 Latin America Antineoplastic Drugs Revenue by Application (2017-2028)
9.3 Latin America Antineoplastic Drugs Market Size by Country
9.3.1 Latin America Antineoplastic Drugs Sales by Country (2017-2028)
9.3.2 Latin America Antineoplastic Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antineoplastic Drugs Market Size by Type
10.1.1 Middle East and Africa Antineoplastic Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antineoplastic Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Antineoplastic Drugs Market Size by Application
10.2.1 Middle East and Africa Antineoplastic Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antineoplastic Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Antineoplastic Drugs Market Size by Country
10.3.1 Middle East and Africa Antineoplastic Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antineoplastic Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Hoffmann-La Roche
11.1.1 Hoffmann-La Roche Corporation Information
11.1.2 Hoffmann-La Roche Overview
11.1.3 Hoffmann-La Roche Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Hoffmann-La Roche Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hoffmann-La Roche Recent Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Overview
11.2.3 Amgen Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Amgen Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Baxter Healthcare
11.4.1 Baxter Healthcare Corporation Information
11.4.2 Baxter Healthcare Overview
11.4.3 Baxter Healthcare Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Baxter Healthcare Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Baxter Healthcare Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Corporation Information
11.5.2 Boehringer Ingelheim Overview
11.5.3 Boehringer Ingelheim Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Boehringer Ingelheim Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Boehringer Ingelheim Recent Developments
11.6 Aspen Global
11.6.1 Aspen Global Corporation Information
11.6.2 Aspen Global Overview
11.6.3 Aspen Global Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Aspen Global Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Aspen Global Recent Developments
11.7 Bayer AG
11.7.1 Bayer AG Corporation Information
11.7.2 Bayer AG Overview
11.7.3 Bayer AG Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bayer AG Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bayer AG Recent Developments
11.8 Teva pharmaceutical Industries
11.8.1 Teva pharmaceutical Industries Corporation Information
11.8.2 Teva pharmaceutical Industries Overview
11.8.3 Teva pharmaceutical Industries Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Teva pharmaceutical Industries Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Teva pharmaceutical Industries Recent Developments
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Corporation Information
11.9.2 Johnson & Johnson Overview
11.9.3 Johnson & Johnson Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Johnson & Johnson Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Johnson & Johnson Recent Developments
11.10 Merc & Co.
11.10.1 Merc & Co. Corporation Information
11.10.2 Merc & Co. Overview
11.10.3 Merc & Co. Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Merc & Co. Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Merc & Co. Recent Developments
11.11 Pfize
11.11.1 Pfize Corporation Information
11.11.2 Pfize Overview
11.11.3 Pfize Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Pfize Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Pfize Recent Developments
11.12 Accord Healthcare
11.12.1 Accord Healthcare Corporation Information
11.12.2 Accord Healthcare Overview
11.12.3 Accord Healthcare Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Accord Healthcare Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Accord Healthcare Recent Developments
11.13 Genentech
11.13.1 Genentech Corporation Information
11.13.2 Genentech Overview
11.13.3 Genentech Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Genentech Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Genentech Recent Developments
11.14 Lundbeck
11.14.1 Lundbeck Corporation Information
11.14.2 Lundbeck Overview
11.14.3 Lundbeck Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Lundbeck Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Lundbeck Recent Developments
11.15 AbbVie
11.15.1 AbbVie Corporation Information
11.15.2 AbbVie Overview
11.15.3 AbbVie Antineoplastic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 AbbVie Antineoplastic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 AbbVie Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antineoplastic Drugs Industry Chain Analysis
12.2 Antineoplastic Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antineoplastic Drugs Production Mode & Process
12.4 Antineoplastic Drugs Sales and Marketing
12.4.1 Antineoplastic Drugs Sales Channels
12.4.2 Antineoplastic Drugs Distributors
12.5 Antineoplastic Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antineoplastic Drugs Industry Trends
13.2 Antineoplastic Drugs Market Drivers
13.3 Antineoplastic Drugs Market Challenges
13.4 Antineoplastic Drugs Market Restraints
14 Key Findings in The Global Antineoplastic Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer